| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |